von Delius S, Lersch C, Schulte-Frohlinde E, Fend F, Dobritz M, Schmid R M, Eckel F
Department of Internal Medicine II, Technical University of Munich, Klinikum rechts der Isar, Munich, Germany.
Z Gastroenterol. 2006 Jan;44(1):39-42. doi: 10.1055/s-2005-858567.
The occurrence of primary hepatocellular carcinoma (HCC) in patients with hereditary hemochromatosis (HH) is well known. Thereby, the development of liver cirrhosis seems to be a prerequisite. Whether or not a hepatic iron overload in the context of hereditary hemochromatosis is an independent risk factor for HCC remains unclear. To date there are only a few reports about HCC arising in non-cirrhotic livers in the presence of HH. We report the case of a 64-year-old man who presented to our outpatient clinic with HCC. Liver cirrhosis could be excluded. Detailed exploration of the patient's history revealed that he had been treated by venesection for about 10 years up to 15 years ago. Subsequent investigations showed an elevated serum ferritin and transferrin saturation. The diagnosis of HH was confirmed by genetic testing, with homozygosity for the Cys282Tyr mutation. The patient received palliative chemotherapy and finally died 15 months after initial diagnosis of HCC.
遗传性血色素沉着症(HH)患者发生原发性肝细胞癌(HCC)已为人所知。因此,肝硬化的发展似乎是一个先决条件。遗传性血色素沉着症背景下的肝脏铁过载是否为HCC的独立危险因素仍不清楚。迄今为止,仅有少数关于HH患者非肝硬化肝脏中发生HCC的报道。我们报告了一例64岁男性因HCC前来我院门诊就诊的病例。可排除肝硬化。对患者病史的详细探究显示,他在15年前接受了约10年的放血治疗。随后的检查显示血清铁蛋白升高和转铁蛋白饱和度升高。基因检测证实为HH,存在Cys282Tyr突变纯合子。该患者接受了姑息化疗,最终在HCC初诊后15个月死亡。